Enhanced muscle by myostatin propeptide increases adipose tissue adiponectin, PPAR-α, and PPAR-γ expressions

Biochemical and Biophysical Research Communications

Volumn 369, Issue 2, 2008, Pages 767-773

  Suzuki, Shana T N ^a   Zhao, Baoping ^a   Yang, Jinzeng ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Adipose tissue; High fat diet; Insulin resistance; Muscle growth; Obesity

Indexed keywords

ADIPONECTIN; FAT; MESSENGER RNA; MYOSTATIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN PRECURSOR;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIDIDYMIS FAT; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; MALE; MESENTERY; MOUSE; MUSCLE GROWTH; MUSCLE MASS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE;

ADIPOSE TISSUE; ANIMALS; DIETARY FATS; GENE EXPRESSION REGULATION; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; PPAR ALPHA; PPAR GAMMA; TRANSFORMING GROWTH FACTOR BETA;

MUS; MUS MUSCULUS;

EID: 40849086138     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.092     Document Type: Article

References (23)

1. National Center for Chronic Disease Prevention and Health Promotion, Behavioral Risk Factor Surveillance System. http://www.cdc.gov/brfss/index.htm 2007.
2. Grundy S.M. Metabolic syndrome: a multiplex cardiovascular risk factor. J. Clin. Endocrinol. Metab. 92 (2007) 399-404
3. Gil-Campos M., Canete R.R., and Gil A. Adiponectin the missing link in insulin resistance and obesity. Clin. Nutr. 23 (2004) 963-974
4. Boucher J. Adipokine expression profile in adipocytes of different mouse models of obesity. Horm. Metab. Res. 37 (2005) 761-767
5. Berg A.H., Combs T.P., Du X., Brownlee M., and Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7 (2002) 947-953
6. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
7. Adamczak M., Wiecek A., Funahashi T., Chudek J., Kokot F., and Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am. J. Hypertens. 16 (2003) 72-75
8. Hu E., Liang P., and Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271 (1996) 10697-10703
9. Combs T.P., Berg A.H., Obici S., Scherer P.E., and Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 108 (2001) 1875-1881
10. Muoio D.M., Way J.M., Tanner C.J., Winegar D.A., Kliewer S.A., Houmard J.A., Kraus W.E., and Dohm G.L. Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 51 (2002) 901-909
11. Walczak R., and Tontonoz P. PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. J. Lipid Res. 43 (2002) 177-186
12. Yang J., Ratovitski T., Brady J.P., Solomon M.B., Wells K.D., and Wall R.J. Expression of myostatin pro domain results in muscular transgenic mice. Mol. Reprod. Dev. 60 (2001) 351-361
13. Zhao B., Wall R.J., and Yang J. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem. Biophys. Res. Commun. 337 (2005) 248-255
14. Yang J., and Zhao B. Postnatal expression of myostatin propeptide cDNA maintained high muscle growth and normal adipose tissue mass in transgenic mice fed a high-fat diet. Mol. Reprod. Dev. 73 (2006) 462-469
15. Kinkel M.D., and Horton Jr. W.E. Coordinate down-regulation of cartilage matrix gene expression in Bcl-2 deficient chondrocytes is associated with decreased SOX9 expression and decreased mRNA stability. J. Cell Biochem. 88 (2003) 941-953
16. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 25 (2001) 402-408
17. Okuno A., Tamemoto H., Tobe K., Ueki K., Mori Y., Iwamoto K., Umesono K., Akanuma Y., Fujiwara T., Horikoshi H., Yazaki Y., and Kadowaki T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 101 (1998) 1354-1361
18. FM F., McTernan P.G., Valsamakis G., Chetty R., Harte A.L., Anwar A.J., Starcynski J., Crocker J., Barnett A.H., McTernan C.L., and Kumar S. Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. Horm. Metab. Res. 34 (2002) 650-654
19. Guo K.Y., Halo P., Leibel R.L., and Zhang Y. Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R112-R119
20. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89 (2004) 2548-2556
21. Ferre F. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53 Suppl. 1 (2004) S43-S50
22. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., Okada-Iwabu M., Kawamoto S., and Kadowaki T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13 (2007) 332-339
23. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., and Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52 (2003) 655-663